Rapid, Onsite COVID-19 Detection

NACompletedINTERVENTIONAL
Enrollment

93

Participants

Timeline

Start Date

July 13, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
COVID-19Sars-CoV2
Interventions
DEVICE

Rapid Onsite COVID-19 Detection

saliva assay test for high concentrations of SARS-CoV-2

Trial Locations (1)

53711

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

AIDS Vaccine Research Lab

UNKNOWN

lead

University of Wisconsin, Madison

OTHER